A PROMIS®ing new measure for quantifying emotion dysregulation in toddlers and preschoolers: Development of the Emotion Dysregulation Inventory-Young Child.
Clinical
Brief report: Convergence and discrepancy between self- and informant-reported depressive symptoms in young autistic adults.
Quantifying neurobehavioral profiles across neurodevelopmental genetic syndromes and idiopathic neurodevelopmental disorders.
Health supervision for children and adolescents with 16p11.2 deletion syndrome.
Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder.
Validation of a modified version of the gross motor function measure in PPPR5D related neurodevelopmental disorder.
Beyond the diagnosis: Evaluation of quality-of-life measures and family functioning in SLC6A1-related neurodevelopmental disorder.
Association of behavioural and social-communicative profiles in children with 16p11.2 copy number variants: a multi-site study.
Increased anticholinergic medication use in middle-aged and older autistic adults and its associations with self-reported memory difficulties and cognitive decline.
An examination of perceived stress and emotion regulation challenges as mediators of associations between camouflaging and internalizing symptomatology.
- Previous Page
- Viewing
- Next Page